Cours Bovie Medical Corporation Nyse
Actions
US10211F1003
Equipement, fournitures et distribution médicale
CA 2024 * | 50,01 M 45,4 M | CA 2025 * | 54,67 M 49,64 M | Capitalisation | 49,54 M 44,98 M |
---|---|---|---|---|---|
Résultat net 2024 * | -26 M -23,61 M | Résultat net 2025 * | -24 M -21,79 M | VE / CA 2024 * | 0,99 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 0,91 x |
PER 2024 * |
-1,91
x | PER 2025 * |
-2,11
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 82,08% |
Dernier transcript sur Bovie Medical Corporation
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Charles Goodwin
CEO | Chief Executive Officer | 58 | 15/12/17 |
Matthew Hill
DFI | Director of Finance/CFO | 56 | 04/12 |
Kari Larson
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Lawrence Waldman
BRD | Director/Board Member | 77 | 15/03/11 |
Craig Swandal
BRD | Director/Board Member | 63 | 09/03/18 |
John Andres
BRD | Director/Board Member | 66 | 17/07/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
-4,82% | 182 Md | |
+1,38% | 110 Md | |
-2,82% | 68,11 Md | |
+0,69% | 50,53 Md | |
+8,54% | 44,8 Md | |
+2,84% | 40,7 Md | |
+20,50% | 32,25 Md | |
+1,72% | 26,53 Md | |
+15,25% | 25,02 Md |